Published in Int J Radiat Oncol Biol Phys on January 01, 1998
Promise of definitive chemoradiotherapy for esophageal cancer balanced with late radiation toxicity: an old but new issue. J Gastroenterol (2006) 1.75
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS). BMC Surg (2008) 1.15
Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus (2010) 1.07
Radiobiological determination of dose escalation and normal tissue toxicity in definitive chemoradiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys (2014) 1.02
Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res (2013) 0.99
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer. Radiother Oncol (2012) 0.88
Predicted risks of radiogenic cardiac toxicity in two pediatric patients undergoing photon or proton radiotherapy. Radiat Oncol (2013) 0.86
Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer. PLoS One (2015) 0.86
The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol (2015) 0.84
Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters. Radiat Oncol (2013) 0.82
Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans. Radiat Oncol (2016) 0.79
Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model. Oncotarget (2016) 0.76
Fraction size and dose parameters related to the incidence of pericardial effusions: regarding Martel et al. IJROBP 40(1):155-161; 1998. Int J Radiat Oncol Biol Phys (2000) 0.75
Mixed modality treatment planning of accelerated partial breast irradiation: to improve complex dosimetry cases. Radiat Oncol (2011) 0.75
Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update. Medicine (Baltimore) (2016) 0.75
Evaluating inter-campus plan consistency using a knowledge based planning model. Radiother Oncol (2016) 0.75
DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer. Radiat Oncol (2017) 0.75
Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys (1999) 4.24
Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. Cancer (2000) 4.05
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys (1998) 2.97
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol (1995) 2.89
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst (1995) 2.64
A method for incorporating organ motion due to breathing into 3D dose calculations. Med Phys (1999) 2.28
Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol (2000) 2.14
Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys (1994) 2.00
Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer (1999) 1.82
Uncertainties in CT-based radiation therapy treatment planning associated with patient breathing. Int J Radiat Oncol Biol Phys (1996) 1.74
The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys (1992) 1.66
The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys (2001) 1.56
Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys (1995) 1.54
Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys (1996) 1.51
Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging. Int J Radiat Oncol Biol Phys (1998) 1.39
Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol (2000) 1.39
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol (2001) 1.37
Partial irradiation of the liver. Semin Radiat Oncol (2001) 1.35
The impact of treatment complexity and computer-control delivery technology on treatment delivery errors. Int J Radiat Oncol Biol Phys (1998) 1.32
Is uniform target dose possible in IMRT plans in the head and neck? Int J Radiat Oncol Biol Phys (2002) 1.24
Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol (1988) 1.20
Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol (1993) 1.17
A stochastic approach to estimate the uncertainty involved in B-spline image registration. IEEE Trans Med Imaging (2009) 1.16
Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life. Acta Otorhinolaryngol Belg (1999) 1.11
Inclusion of organ deformation in dose calculations. Med Phys (2003) 1.09
Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys (1995) 1.08
Inverse plan optimization accounting for random geometric uncertainties with a multiple instance geometry approximation (MIGA). Med Phys (2006) 1.06
A feasibility study of mutual information based setup error estimation for radiotherapy. Med Phys (2001) 1.05
Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group. J Clin Oncol (1993) 1.03
CT-SPECT fusion plus conjugate views for determining dosimetry in iodine-131-monoclonal antibody therapy of lymphoma patients. J Nucl Med (1994) 1.03
Adjuvant radiotherapy for recurrent granular cell tumor. Cancer (1990) 1.03
Prostate position late in the course of external beam therapy: patterns and predictors. Int J Radiat Oncol Biol Phys (2000) 1.02
Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol (1998) 1.01
Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy. Semin Radiat Oncol (1999) 0.98
The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms. Int J Radiat Oncol Biol Phys (1992) 0.97
Expanding the use and effectiveness of dose-volume histograms for 3-D treatment planning. I: Integration of 3-D dose-display. Int J Radiat Oncol Biol Phys (1994) 0.96
Partial irradiation of the parotid gland. Semin Radiat Oncol (2001) 0.96
Enhanced expression of thymidine kinase in human cells following ionizing radiation. Int J Radiat Oncol Biol Phys (1994) 0.95
Response of sarcomas of bone and of soft tissue to neutron beam therapy. Int J Radiat Oncol Biol Phys (1984) 0.92
A quantitative assessment of the addition of MRI to CT-based, 3-D treatment planning of brain tumors. Radiother Oncol (1992) 0.92
A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys (1997) 0.92
Human pharmacokinetics of WR-2721. Int J Radiat Oncol Biol Phys (1986) 0.92
Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys (1997) 0.91
Automated generation of a four-dimensional model of the liver using warping and mutual information. Med Phys (2003) 0.89
Toxicity of WR-2721 administered in single and multiple doses. Int J Radiat Oncol Biol Phys (1984) 0.89
Pediatric midbrain tumors: a benign subgroup of brainstem gliomas. Pediatr Neurosurg (1995) 0.89
Quantization of setup uncertainties in 3-D dose calculations. Med Phys (1999) 0.89
Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys (1997) 0.88
Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys (1991) 0.88
Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: a retrospective multivariate analysis. Int J Radiat Oncol Biol Phys (1993) 0.87
Radiation therapy as an alternative to surgery in the management of intracranial juvenile nasopharyngeal angiofibroma. Int J Pediatr Otorhinolaryngol (1993) 0.86
Integration of magnetic resonance imaging into radiation therapy treatment planning: I. Technical considerations. Int J Radiat Oncol Biol Phys (1987) 0.86
Measurement of backscatter to the monitor chamber of medical accelerators using target charge. Med Phys (1998) 0.85
Do dose-volume metrics predict pulmonary function changes in lung irradiation? Int J Radiat Oncol Biol Phys (2003) 0.85
Determination of rotations in three dimensions using two-dimensional portal image registration. Med Phys (1998) 0.85
Verification data for electron beam dose algorithms. Med Phys (1992) 0.84
Sensitivity analysis for lexicographic ordering in radiation therapy treatment planning. Med Phys (2012) 0.83
Fast neutrons and misonidazole for malignant astrocytomas. Int J Radiat Oncol Biol Phys (1985) 0.83
An automated image-registration technique based on multiple structure matching. Med Phys (1994) 0.83
Cortical versus medullary thymomas: a useful morphologic distinction? Hum Pathol (1988) 0.83
Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol (1997) 0.83
Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys (1993) 0.83
Three-dimensional motion analysis of an improved head immobilization system for simulation, CT, MRI, and PET imaging. Radiother Oncol (1991) 0.82
Photon activation-15O decay studies of tumor blood flow. Med Phys (1982) 0.82
The effect of patient position and treatment technique in conformal treatment of prostate cancer. Int J Radiat Oncol Biol Phys (1999) 0.82
Three-dimensional treatment planning of astrocytomas: a dosimetric study of cerebral irradiation. Int J Radiat Oncol Biol Phys (1991) 0.82
Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys (1988) 0.82
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys (1990) 0.82
Dose escalation for stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol (1992) 0.82
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid]. Cancer Treat Rep (1986) 0.82
The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys (1995) 0.82
Automated determination of patient setup errors in radiation therapy using spherical radio-opaque markers. Med Phys (1993) 0.81
A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography. Int J Radiat Oncol Biol Phys (1996) 0.81
Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts. Int J Radiat Oncol Biol Phys (1993) 0.80
Response of pancreatic cancer to local irradiation with high-energy neutrons. Cancer (1985) 0.80
Limited small-cell lung cancer: a potentially curable disease. Oncology (Williston Park) (2000) 0.80
Optimal placement of radioisotopes for permanent prostate implants. Radiology (1996) 0.80
A computer-controlled conformal radiotherapy system. I: Overview. Int J Radiat Oncol Biol Phys (1995) 0.80
Results of primary and adjuvant CT-based 3-dimensional radiotherapy for malignant tumors of the paranasal sinuses. Int J Radiat Oncol Biol Phys (1994) 0.80
Isolation of an X-ray-responsive element in the promoter region of tissue-type plasminogen activator: potential uses of X-ray-responsive elements for gene therapy. Radiat Res (1994) 0.80
3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience. Front Radiat Ther Oncol (1996) 0.80
Flattening-filter-based empirical methods to parametrize the head scatter factor. Med Phys (1996) 0.80
Spinal cord dose from standard head and neck irradiation: implications for three-dimensional treatment planning. Radiother Oncol (1998) 0.80
Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy. Int J Radiat Oncol Biol Phys (1988) 0.80
Dosimetric verification of a 3-D electron pencil beam dose calculation algorithm. Med Phys (1994) 0.79
A mathematical model for correcting patient setup errors using a tilt and roll device. Med Phys (1999) 0.79
A room-based diagnostic imaging system for measurement of patient setup. Med Phys (1998) 0.79
A computer-controlled conformal radiotherapy system. II: Sequence processor. Int J Radiat Oncol Biol Phys (1995) 0.78
A computer-controlled conformal radiotherapy system. IV: Electronic chart. Int J Radiat Oncol Biol Phys (1995) 0.78
Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography. Int J Radiat Oncol Biol Phys (1992) 0.78